BIOMAT Database Logo BIOMAT Database Logo

Bee venom immunotherapy. 1980

R M Ford

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001514 Bee Venoms Toxins obtained from Apis mellifera (honey bee) and related species. They contain various enzymes, polypeptide toxins, and other substances, some of which are allergenic or immunogenic or both. These venoms were formerly used in rheumatism to stimulate the pituitary-adrenal system. Apis Venoms,Honeybee Venom,Honeybee Venoms,Apitoxin,Bee Venom,Venom, Bee,Venom, Honeybee,Venoms, Apis,Venoms, Bee,Venoms, Honeybee

Related Publications

R M Ford
Bee venom immunotherapy.
October 1980, JAMA,
R M Ford
Bee venom immunotherapy.
January 1990, Inforum (Adelaide, S. Aust.),
R M Ford
Bee venom immunotherapy.
February 1984, The Medical journal of Australia,
R M Ford
Bee venom immunotherapy.
January 1983, The Medical journal of Australia,
R M Ford
Immunotherapy in bee sting hypersensitivity. Bee venom versus wholebody extract.
December 1979, Allergy,
R M Ford
Bee venom immunotherapy: clinical and immunologic observations.
December 1981, Annals of allergy,
R M Ford
[Immunotherapy in patients allergic to bee venom].
January 2010, Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993),
R M Ford
Human albumin causes anaphylaxis during bee venom immunotherapy.
June 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
R M Ford
Mechanisms of immunotherapy to wasp and bee venom.
September 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
R M Ford
Bee venom immunotherapy - how early is it effective?
March 2010, Allergy,
Copied contents to your clipboard!